Successful use of calcium channel blocker for management of arterio-venous malformations following Fontan procedure.

Amlodipine/administration & dosage; Arteriovenous Malformations/drug therapy/etiology; Calcium Channel Blockers/administration & dosage; Child, Preschool; Female; Fontan Procedure/adverse effects; Humans; Hypoplastic Left Heart Syndrome/surgery; Nitric Oxide/therapeutic use; Stents; Arteriovenous malformations; Fontan; amlodipine; hypoxemia; intensive care

Abstract :

[en] In diffuse forms of arteriovenous malformation following Fontan procedure, "classical" medical therapy, inhaled nitric oxide and sildenafil, may play a role, until re-direction of hepatic flow to pulmonary circulation cures it. However, in refractory cases, as reported in our 2-year-old patient, unusual medications such as calcium channel blockers can be tried and continued if patients respond adequately.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Hamzeh, Ramzi

Bulbul, Ziad

ASSY, Jana ; Centre Hospitalier Universitaire de Liège - CHU > Département de Pédiatrie > Service de pédiatrie

Language :

English

Title :

Successful use of calcium channel blocker for management of arterio-venous malformations following Fontan procedure.

Publication date :

2018

Journal title :

Cardiology in the Young

ISSN :

1047-9511

eISSN :

1467-1107

Publisher :

Cambridge University Press, United Kingdom

Volume :

Issue :

Pages :

1468-1470

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 15 February 2022

Statistics

Number of views

41 (1 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Duncan BW, Desai S. Pulmonary arteriovenous malformations after cavopulmonary anastomosis. Ann Thorac Surg 2003; 76: 1759-1766.
Mcfaul RC, Tajik AJ, Mair DD, Danielson GK, Seward JB. Development of pulmonary arteriovenous shunt after superior vena cava-right pulmonary artery (Glenn) anastomosis. Report of four cases. Circulation 1977; 55: 212-216.
Kavarana MN, Jones JA, Stroud RE, Bradley SM, Ikonomidis JS, Mukherjee R. Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications. Expert Rev Cardiovasc Ther 2014; 12: 703-713.
Carlo WF, Nelson DP. Inhaled nitric oxide improves oxygen saturation in children with pulmonary arteriovenous malformations after the Fontan procedure. Pediatr Crit Care Med 2011; 12: e152-4.
Pantaleoni J, Parsapour K, Kon A. Inhaled nitric oxide and sildenafil therapy for a pediatric patient with multiple pulmonary arteriovenous malformations. J Pediatr Intensive Care 2015; 2: 181-185.
Bhate S, Rossiter-Thornton M, Cooper SG, et al. Use of sildenafil and nitric oxide in the management of hypoxemia owing to pulmonary arteriovenous fistulas after total cavopulmonary connection. J Thorac Cardiovasc Surg 2008; 135: 446-448.
Papagiannis J, Apostolopoulou S, Sarris G, Rammos S. Diagnosis and management of pulmonary arteriovenous malformations. Images Paediatr Cardiol 2002; 4: 33-49.
Berkels R, Taubert D, Bartels H, Breitenbach T, Klaus W, Roesen R. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2003; 70: 39-45.
Sands A, Dalzell E, Craig B, Shields M. Multiple intrapulmonary arteriovenous fistulas in childhood. Pediatr Cardiol 2000; 21: 493-496.